TY - GEN
T1 - ELIMED a new concept of hadrontherapy with laser-driven beams
AU - Cirrone, Pablo G.A.
AU - Cuttone, Giacomo
AU - Korn, Georg
AU - Maggiore, Mario
AU - Margarone, Daniele
AU - Bji, Bijan
AU - Calabretta, Luciano
AU - Cali, Claudio
AU - Caruso, Antonio
AU - Caruso, Fortunato
AU - Cavallaro, Salvatore
AU - Gammino, Santo
AU - Malfa, Giuseppe
AU - Manti, Lorenzo
AU - Passarello, Santi
AU - Prokupek, Jan
AU - Renis, Marcella
AU - Romano, Francesco
AU - Schillaci, Francesco
AU - Tomasello, Barbara
AU - Torrisi, Lorenzo
AU - Tramontana, Antonella
AU - Trovato, Biagio
AU - Zappala, Emilio
PY - 2012/12/1
Y1 - 2012/12/1
N2 - ELIMED (Medical Applications at Extreme Light Infrastructure) is a task-force originally born by an idea of ELI-Beams (Prague, CZ)and INFN-LNS (Italian Institute for Nuclear Physics of Catania, I) researchers. It now involves other groups interested in the possibility to design and develop a new generation of hadrontherapy facilities using laser-accelerated ion beams. ELIMED main goal is to perform proof-of-principle experiments aimed to demonstrate that laser-accelerated high-energy proton beams (up to 70MeV in the first phase) can be potentially used for the specific case of ocular proton therapy. For this purpose new devices for beam handling and transport will be developed as well as new methods for radiobiology and dosimetry. The involvement of INFN-LNS group takes advantage of the well-established expertise in dosimetry measurements and Monte Carlo calculations for medical physics, which has been achieved in several years of eye tumor treatments in the CATANA proton therapy facility. Recently, in the framework of an INFN activity, they have also designed, fabricated, calibrated and experimentally tested at PALS laser laboratory (Cz) a Thomson Parabola ion spectrometer with a wide acceptance and able to characterize laser-driven proton beams up to 20MeV.
AB - ELIMED (Medical Applications at Extreme Light Infrastructure) is a task-force originally born by an idea of ELI-Beams (Prague, CZ)and INFN-LNS (Italian Institute for Nuclear Physics of Catania, I) researchers. It now involves other groups interested in the possibility to design and develop a new generation of hadrontherapy facilities using laser-accelerated ion beams. ELIMED main goal is to perform proof-of-principle experiments aimed to demonstrate that laser-accelerated high-energy proton beams (up to 70MeV in the first phase) can be potentially used for the specific case of ocular proton therapy. For this purpose new devices for beam handling and transport will be developed as well as new methods for radiobiology and dosimetry. The involvement of INFN-LNS group takes advantage of the well-established expertise in dosimetry measurements and Monte Carlo calculations for medical physics, which has been achieved in several years of eye tumor treatments in the CATANA proton therapy facility. Recently, in the framework of an INFN activity, they have also designed, fabricated, calibrated and experimentally tested at PALS laser laboratory (Cz) a Thomson Parabola ion spectrometer with a wide acceptance and able to characterize laser-driven proton beams up to 20MeV.
UR - http://www.scopus.com/inward/record.url?scp=84881564088&partnerID=8YFLogxK
U2 - 10.1109/NSSMIC.2012.6551462
DO - 10.1109/NSSMIC.2012.6551462
M3 - Conference contribution
AN - SCOPUS:84881564088
SN - 9781467320306
T3 - IEEE Nuclear Science Symposium Conference Record
SP - 1999
EP - 2002
BT - 2012 IEEE Nuclear Science Symposium and Medical Imaging Conference Record, NSS/MIC 2012
T2 - 2012 IEEE Nuclear Science Symposium and Medical Imaging Conference Record, NSS/MIC 2012
Y2 - 29 October 2012 through 3 November 2012
ER -